APR 26, 2017 09:54 PM PDT

Could soy protein ease irritable bowel diseases?

Eating a diet that includes foods containing soy protein may work to alleviate some symptoms of inflammatory bowl diseases, a new study with mice suggests.

The findings are significant because inflammatory bowel diseases—including ulcerative colitis and Crohn’s disease—are characterized by either continuous or periodic inflammation of the colon and represent a significant risk factor for colon cancer. Also known as IBD, inflammatory bowel diseases affect nearly 4 million people worldwide and have an economic impact of more than $19 billion annually in the United States alone.

The development of dietary strategies to mitigate IBD is of considerable public health importance, says Joshua Lambert, associate professor of food science in the Penn State College of Agricultural Sciences. He says his team found that soy-protein concentrate can exert antioxidant and cytoprotective effects in cultured human bowel cells and can moderate the severity of inflammation in mice that have an induced condition similar to ulcerative colitis.

Zachary Bitzer and Amy Wopperer, former graduate students in the department of food science and the lead researchers, substituted soy-protein concentrate into the diet of the mice and removed corresponding amounts of the other protein sources, equaling about 12 percent. They kept human equivalents in mind as they determined the amount.

We didn’t want to get carried away with using doses that were really high and would crowd out all the other protein that was there,” Bitzer says. “Instead, we wanted to find a scenario that was going to fit into a more human-relevant situation.

The dietary soy-protein concentrate at the 12-percent dose level ameliorated body-weight loss and swelling of the spleen in the mice with induced inflammatory bowel disease.

“Soy-protein concentrate mitigates markers of colonic inflammation and loss of gut barrier function in the mice with induced IBD,” Wopperer says.

Follow-on studies will focus on whether the results of this research with mice, published in the Journal of Nutritional Biochemistry, are readily translatable to people. Because soy protein is a common food ingredient—often used as a meat substitute and commonly referred to as “texturized vegetable proteins” in ingredient lists—Lambert believes human studies could be arranged in the near future.

“Since it is already out there commercially, that makes it more straightforward,” he says. “But practically speaking, the actual clinical studies are a little bit out of our area of expertise.” Lambert believes the team will find a collaborator outside his lab to help with human studies.

Lambert’s laboratory soon will start a related investigation of whether the inflammation-moderating effects triggered in the mouse colons are due solely to the soy protein or also may be caused by soy fiber. Soy-protein concentrate is 70 percent protein by weight, but it also has quite a bit of soybean fiber in it, he explains.

The Pennsylvania Soybean Board, the American Institute for Cancer Research, and the US Department of Agriculture’s Hatch Program supported this research. The Roger and Barbara Claypoole Distinguished Graduate Fellowship in the College of Agricultural Sciences supported, in part, both Wopperer and Bitzer. The Penn State Genomics Core Facility provided technical assistance and primer synthesis services.

Source: Penn State

Original Study DOI: 10.1016/j.jnutbio.2016.11.012

This article was originally published on futurity.org


About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
MAY 22, 2018
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
JUL 05, 2018
Health & Medicine
JUL 05, 2018
Is Testing Everyone for Hep C Necessary?
Cases of Hepatitis C, known as Hep C or HCV, are on the rise. In the United States, the CDC reports that there were approximately 3,000 new cases of hepati...
JUL 19, 2018
JUL 19, 2018
Mom's Microbiome has a Big Impact on Kid's Autism Risk
For many years, scientists have been trying to learn more about the causes of autism....
JUL 24, 2018
JUL 24, 2018
T Cells Aggravate Parkinson's Disease
The T cell, Th17, that kill nerve cells have increased levels in the midbrain of Parkinson's patients leading to destruction of neuronal cells....
AUG 21, 2018
AUG 21, 2018
T cells Trapped by Brain Cancer
Brain tumors prevent T cells from escaping the bone marrow by altering levels of the S1P1 protein....
AUG 29, 2018
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
Loading Comments...